
    
      20 person of vaccinated individuals who have HBsAb<10 after 3 dose hepatitis B vaccination
      who called Nonresponders will be randomly allocated in 2 groups. one group receive short-term
      Atorvastatin and other group receive placebo.both group will be vaccinated with hepatitis B
      vaccine and then immunity response will be measured.
    
  